IndraLab
Statements
reach
"More recently, GSK3 was shown to enhance proteasomal degradation of VEGFR-2 by regulating the binding of β-transducin repeats containing E3 ubiquitin protein ligase to VEGFR-2 (29), and GSK3 activity is inhibited by AKT that phosphorylates the serine residues Ser21 in GSK3α and Ser9 in GSK3β (30)."
reach
"In our previous study, we demonstrated that the phosphorylation of GSK3β at serine 9 by activated AKT plays a role in the hair-inductive properties of DP cells via the activation of Wnt/β-catenin signaling, which is one of the most important signaling pathways for hair growth in HFs [12]."
reach
"GSK3β is part of several signal transduction pathways and is involved in the signaling induced by kinases such as AKT, which phosphorylates GSK3β at serine 9, or AMPK, i.e., kinases, for which a mitochondrial localization has been described (see text and [50]) and that contribute to myocardial I/R injury and the protection from it."
reach
"These mediators activate phosphatidylinositol-3-kinase (PI3K) and Akt which phosphorylates GSK3 at an amino terminal serine residue (Ser21 on GSK3alpha and Ser9 on GSK3beta) creating a pseudo-substrate motif that inhibits the enzyme 's activity and allows activation of downstream effectors like glycogen synthase and the mammalian target of rapamycin (mTOR)."
reach
"Glycogen synthase kinase 3 (GSK3) phosphorylates the N-terminal phosphodegron in TAZ, increasing its binding to the Skp1-Cullin-F-box (SCF) subunit of E3 Ub ligase, βTrCP, leading to TAZ ubiquitylation and degradation.38 GSK3 activity is suppressed by AKT phosphorylating serine 9 in GSK3β.39 We found leader cells exhibited higher GSK3β phosphorylation than follower cells that correlated with their elevated pAKT expression (Figure 5C)."
reach
"In the present study, GSK3β was identified as a tumor suppressor in PC-9G cells without EGFR mutations, suggesting that the role of GSK3β may vary according to whether EGFR is mutated or not in gefitinib-resistant NSCLC.The PI3K/AKT pathway serves a key role in cancer cells that are resistant to EGFR-TKIs (22,32), and AKT phosphorylates GSK3β at serine 9 (33,34)."